Michelle Angrish

Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization

Katie Paul Friedman, Matthew Gagné, Lit‐Hsin Loo et al. · Toxicological Sciences · 2019 · 238 citations · Full text

Adverse outcome pathway networks I: Development and applications

Dries Knapen, Michelle Angrish, Marie Fortin et al. · Environmental Toxicology and Chemistry · 2018 · 223 citations · Full text

Environmental Monitoring, System Medicine, Aop Framework +20

Adverse outcome pathway networks II: Network analytics

Daniel L. Villeneuve, Michelle Angrish, Marie Fortin et al. · Environmental Toxicology and Chemistry · 2018 · 142 citations · Full text

Aop Descriptions, Interaction Network, Network Analysis +18

Endogenous and Synthetic ABHD5 Ligands Regulate ABHD5-Perilipin Interactions and Lipolysis in Fat and Muscle

Matthew A. Sanders, Franck Madoux, Ljiljana Mladenovic et al. · Cell Metabolism · 2015 · 108 citations · Full text

Oxysterol, Biochemistry, Metabolic Regulation +3

Integrating Publicly Available Data to Generate Computationally Predicted Adverse Outcome Pathways for Fatty Liver

Shannon Bell, Michelle Angrish, Charles E. Wood et al. · Toxicological Sciences · 2016 · 75 citations · Full text